Hydrogen peroxide builds a better fat stem cell aging model, and fisetin cuts senescence markers

Why it matters: As we age, the mesenchymal stromal cells in fat tissue (AD-MSCs) can become senescent. They stop dividing and secrete inflammatory molecules known as the senescence-associated secretory phenotype (SASP). This is linked to chronic low-grade inflammation, impaired fat-cell formation, insulin resistance and age-related disease. Reliable lab models of this process are needed to screen senolytic and senomorphic compounds, and fisetin, a plant flavonoid, is one of the most discussed candidates.

What was studied: Researchers isolated AD-MSCs from subcutaneous fat of eight adults (mean age about 37) and confirmed their identity by tri-lineage differentiation. They compared replicative aging (serial passaging up to passage 18–20) with stress-induced aging using a 24-hour exposure to either LPS (1 μg/mL) or H2O2 (50 μM), followed by 7 days of culture. Senescence was judged by SA-β-gal staining, SASP cytokines (IL-1β, IL-6, IL-8, TNF-α, MCP-1) and the cell cycle arrest proteins p16, p21 and p53. Fisetin (50 μM) was then tested on H2O2-aged cells for 24 hours or 7 days.

Key results: Serially passaged cells showed rising SA-β-gal positivity from passage 6, higher IL-1β and MCP-1 at later passages, and higher p16, p21 and p53 at passages 12–18. For stress induction, H2O2 produced 76.9% SA-β-gal-positive cells versus 9.0% for LPS and 1.3% for controls. Both inducers raised some SASP factors to a similar degree, but only H2O2 significantly raised the cell cycle arrest markers. In the fisetin experiment, SA-β-gal-positive cells were 2.0% in controls, 81.7% after H2O2, and 19.1% and 13.0% after 24 hours and 7 days of fisetin. Fisetin lowered MCP-1 (most strongly at 7 days) and IL-1β (at 7 days). IL-8 fell at 24 hours but rose at 7 days, and IL-6 and TNF-α did not change significantly. Fisetin-treated cells had significantly higher p21, and p53 trended upward without reaching significance.

Implications: The H2O2 model is simple, quick and produces a strong senescent phenotype, so it could serve as a screening platform for senotherapeutics in adipose-derived stem cells. The authors interpret the p53/p21 rise as consistent with fisetin-triggered apoptosis of senescent cells, as seen in other cell types, but they did not test this.

Caveats: Findings are in vitro, from eight donors, and without correction for multiple comparisons. Cell death, viability after treatment and apoptosis markers were not reported, so the fall in SA-β-gal staining cannot be attributed to selective killing of senescent cells. Other senescence markers such as γH2AX, telomere length and lipofuscin were not assessed, and the fisetin effects on SASP and p21 were mixed. The model did not include older donors or non-obese controls, and nothing here shows clinical benefit in people.